Type:
---AlogP:
6.34Polar Surface Area:
45.23HBA:
3HBD:
1#RO5 Violations:
1#Rotatable Bonds:
3Passes Ro3:
NQED Weighted:
0.49DETAILSType:
---AlogP:
5.46Polar Surface Area:
45.23HBA:
3HBD:
1#RO5 Violations:
1#Rotatable Bonds:
3Passes Ro3:
NQED Weighted:
0.65DETAILS- ALA5198308
Name:
Cyclohexyl-N-(1H-indazol-6-yl)piperazine-1-carboxamideMol. Formula:
C18H25N5OM.W.:
327.43Type:
---AlogP:
2.95Polar Surface Area:
73.05HBA:
3HBD:
3#RO5 Violations:
---#Rotatable Bonds:
2Passes Ro3:
NQED Weighted:
0.79DETAILS - ALA5198154
Name:
(S)-N-(3-chlorophenyl)-2-(5-phenylthiazol-2-yl)pyrrolidine-1-carboxamideMol. Formula:
C20H18ClN3OSM.W.:
383.90Type:
---AlogP:
5.83Polar Surface Area:
45.23HBA:
3HBD:
1#RO5 Violations:
1#Rotatable Bonds:
3Passes Ro3:
NQED Weighted:
0.62DETAILS - ALA5197804
Name:
N-(1H-Indazol-5-yl)-4-(3-methoxypyridin-2-yl)piperazine-1-carboxamideMol. Formula:
C18H20N6O2M.W.:
352.40Type:
---AlogP:
2.32Polar Surface Area:
86.38HBA:
5HBD:
2#RO5 Violations:
---#Rotatable Bonds:
3Passes Ro3:
NQED Weighted:
0.76DETAILS - ALA5197704
Name:
4-(2,3-Dichlorophenyl)-N-(1H-indazol-5-yl)piperazine-1-carboxamideMol. Formula:
C18H17Cl2N5OM.W.:
390.27Type:
---AlogP:
4.22Polar Surface Area:
64.26HBA:
3HBD:
2#RO5 Violations:
---#Rotatable Bonds:
2Passes Ro3:
NQED Weighted:
0.69DETAILS Type:
---AlogP:
5.37Polar Surface Area:
58.12HBA:
4HBD:
1#RO5 Violations:
1#Rotatable Bonds:
3Passes Ro3:
NQED Weighted:
0.60DETAILSType:
---AlogP:
5.97Polar Surface Area:
45.23HBA:
3HBD:
1#RO5 Violations:
1#Rotatable Bonds:
3Passes Ro3:
NQED Weighted:
0.59DETAILSType:
---AlogP:
5.97Polar Surface Area:
45.23HBA:
3HBD:
1#RO5 Violations:
1#Rotatable Bonds:
3Passes Ro3:
NQED Weighted:
0.59DETAILS- ALA5196182
Name:
4-(2-Chlorophenyl)-N-(1H-indazol-5-yl)piperazine-1-carboxamideMol. Formula:
C18H18ClN5OM.W.:
355.83Type:
---AlogP:
3.57Polar Surface Area:
64.26HBA:
3HBD:
2#RO5 Violations:
---#Rotatable Bonds:
2Passes Ro3:
NQED Weighted:
0.74DETAILS Type:
---AlogP:
6.34Polar Surface Area:
45.23HBA:
3HBD:
1#RO5 Violations:
1#Rotatable Bonds:
3Passes Ro3:
NQED Weighted:
0.49DETAILS- ALA5203984
Name:
4-(5-Chloropyridin-2-yl)-N-(1H-indazol-5-yl)piperazine-1-carboxamideMol. Formula:
C17H17ClN6OM.W.:
356.82Type:
---AlogP:
2.97Polar Surface Area:
77.15HBA:
4HBD:
2#RO5 Violations:
---#Rotatable Bonds:
2Passes Ro3:
NQED Weighted:
0.74DETAILS - ALA5203890
Name:
4-(3-Chloropyridin-2-yl)-N-(1H-indazol-7-yl)piperazine-1-carboxamideMol. Formula:
C17H17ClN6OM.W.:
356.82Type:
---AlogP:
2.97Polar Surface Area:
77.15HBA:
4HBD:
2#RO5 Violations:
---#Rotatable Bonds:
2Passes Ro3:
NQED Weighted:
0.74DETAILS - ALA5203820
Name:
4-(2,3-Dichlorophenyl)-N-(1-methyl-1H-indazol-6-yl)piperidine-1-carboxamideMol. Formula:
C20H20Cl2N4OM.W.:
403.31Type:
---AlogP:
5.29Polar Surface Area:
50.16HBA:
3HBD:
1#RO5 Violations:
1#Rotatable Bonds:
2Passes Ro3:
NQED Weighted:
0.63DETAILS Type:
---AlogP:
5.74Polar Surface Area:
88.37HBA:
5HBD:
1#RO5 Violations:
1#Rotatable Bonds:
4Passes Ro3:
NQED Weighted:
0.42DETAILS